Stock listing
A2DLU2 Stock Price, News, Filings & Events — Oncopeptides Ab
Selected listing: A2DLU2 · LS · EUR · DE
This page tracks Oncopeptides Ab's A2DLU2:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DLU2:LS. A2DLU2:LS is the stock-level entry point for investors researching Oncopeptides Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2DLU2:LS
- Asset type
- Stock
- Market cap
- $81.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Oncopeptides Ab A2DLU2:LS stock context
This page tracks Oncopeptides Ab's A2DLU2:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DLU2:LS. A2DLU2:LS is the stock-level entry point for investors researching Oncopeptides Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Oncopeptides Ab
Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti in Central and Eastern Europe
May 26, 2026
Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs
May 20, 2026
Oncopeptides secures regulatory approval to start Window-of-Opportunity study in glioblastoma from Norwegian authorities
May 19, 2026
Oncopeptides publishes Q1 report 2026
May 13, 2026
Oncopeptides intends to submit type II variation to expand Pepaxti label to include third line treatment
May 11, 2026
Oncopeptides Ab earnings calls
Oncopeptides AB (publ) (ONCO) Q2 2026 Earnings Call
August 27, 2026 · Replay with transcript and chapters
Oncopeptides AB (publ) (ONCO) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Oncopeptides AB (publ) (ONCO) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
Oncopeptides AB (publ) (ONCO) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Oncopeptides AB (publ) (ONCO) Q2 2025 Earnings Call
August 21, 2025 · Replay with transcript and chapters
Oncopeptides AB (publ) (ONCO) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Oncopeptides Ab
Oncopeptides Ab investor report
Review AI stock analysis and investor report context for A2DLU2:LS.
Oncopeptides Ab company profile
View the public company page for Oncopeptides Ab on 6ix.
Oncopeptides Ab news
Read company news and market updates connected to Oncopeptides Ab.
Oncopeptides Ab investor events
Find investor webinars, events, and replay context for Oncopeptides Ab.
Alternate listings
ONCO:OMXSTO
SE · SEK
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
A2DLU2:LSX
DE · EUR
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
0RN4:LSIN
GB · SEK
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
OND:GETTEX
DE · EUR
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
ONCOS:AQUISEU
GB · SEK
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
OND:SWB
DE · EUR
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
ONCOS:AQUISUK
GB · SEK
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
OND:DUS
DE · EUR
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
OND:FWB
DE · EUR
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
ONCOS:TURQUOISE
GB · SEK
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.
OND:MUN
DE · EUR
Alternate listing for Oncopeptides Ab; the primary context on this page is A2DLU2:LS.